Research & Development



  他們以為皇帝就像民間傳說的那樣——英明,勇武,睿智,仁慈且大度。   也是我劉氏太祖高皇帝籠絡淮陰侯韓信時,‘推食食之,解衣衣之’的典故來源。得得去在线   劉據認真的點頭道︰“我記下了。”得得干在线   而那個時候,劉徹已經死了六百年了。   衛皇後嘆息一聲道︰“你就不能跟你父皇稟報一聲,就說想要留幾樣菜式拿給皇長子屬官們享用嗎?”超碰   狗子匆匆的離開了地窖。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo